Entheogen Therapeutics Initiative

Filament Health Corp. (OTCQB: FLHLF) and Jaguar Health, Inc. (NASDAQ: JAGX) have signed a letter of intent for a collaboration agreement. The deal would allow for the extension of both companies’ skillsets towards creating pharmaceutical-grade, standardized drug candidates for diagnoses such...